Ken Fisher’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,395
Closed -$433K 1121
2025
Q3
$433K Sell
4,395
-95
-2% -$9.41K ﹤0.01% 802
2025
Q2
$410K Sell
4,490
-80
-2% -$7.74K ﹤0.01% 819
2025
Q1
$517K Sell
4,570
-678
-13% -$72.5K ﹤0.01% 781
2024
Q4
$554K Buy
5,248
+348
+7% +$37.3K ﹤0.01% 760
2024
Q3
$529K Sell
4,900
-330
-6% -$36K ﹤0.01% 750
2024
Q2
$568K Buy
5,230
+1,184
+29% +$140K ﹤0.01% 762
2024
Q1
$534K Sell
4,046
-1,054
-21% -$132K ﹤0.01% 763
2023
Q4
$621K Sell
5,100
-609
-11% -$68K ﹤0.01% 747
2023
Q3
$641K Sell
5,709
-2
-0% -$254 ﹤0.01% 815
2023
Q2
$832K Hold
5,711
﹤0.01% 810
2023
Q1
$739K Sell
5,711
-841
-13% -$106K ﹤0.01% 805
2022
Q4
$835K Sell
6,552
-360
-5% -$41.8K ﹤0.01% 790
2022
Q3
$723K Buy
6,912
+21
+0.3% +$2.31K ﹤0.01% 715
2022
Q2
$724K Sell
6,891
-329
-5% -$39K ﹤0.01% 661
2022
Q1
$923K Sell
7,220
-141
-2% -$17K ﹤0.01% 636
2021
Q4
$908K Sell
7,361
-1,906
-21% -$249K ﹤0.01% 660
2021
Q3
$1.32M Sell
9,267
-14
-0.2% -$2.06K ﹤0.01% 574
2021
Q2
$1.45M Buy
9,281
+853
+10% +$138K ﹤0.01% 562
2021
Q1
$1.31M Sell
8,428
-707
-8% -$110K ﹤0.01% 577
2020
Q4
$1.37M Sell
9,135
-1,034
-10% -$146K ﹤0.01% 565
2020
Q3
$1.34M Sell
10,169
-5,691
-36% -$743K ﹤0.01% 530
2020
Q2
$1.84M Buy
15,860
+648
+4% +$74.7K ﹤0.01% 497
2020
Q1
$1.49M Sell
15,212
-340
-2% -$44.6K ﹤0.01% 484
2019
Q4
$2.26M Sell
15,552
-74,426
-83% -$10.3M ﹤0.01% 476
2019
Q3
$12M Sell
89,978
-811
-0.9% -$105K 0.01% 340
2019
Q2
$10.4M Sell
90,789
-92
-0.1% -$10.8K 0.01% 357
2019
Q1
$11.3M Sell
90,881
-7,195
-7% -$818K 0.01% 345
2018
Q4
$9.88M Sell
98,076
-163
-0.2% -$18.3K 0.01% 339
2018
Q3
$12.5M Sell
98,239
-8,015
-8% -$953K 0.02% 324
2018
Q2
$11.5M Sell
106,254
-3,993
-4% -$435K 0.01% 336
2018
Q1
$11.7M Sell
110,247
-16,178
-13% -$1.88M 0.02% 330
2017
Q4
$14.8M Sell
126,425
-7,738
-6% -$875K 0.02% 309
2017
Q3
$15.3M Sell
134,163
-1,987
-1% -$229K 0.02% 297
2017
Q2
$17M Sell
136,150
-625
-0.5% -$74.1K 0.03% 284
2017
Q1
$16.2M Sell
136,775
-14,901
-10% -$1.69M 0.03% 271
2016
Q4
$15.2M Sell
151,676
-6,866
-4% -$736K 0.03% 268
2016
Q3
$20M Sell
158,542
-20,217
-11% -$2.5M 0.04% 248
2016
Q2
$21.7M Sell
178,759
-9,886
-5% -$1.12M 0.04% 238
2016
Q1
$20.9M Buy
188,645
+4,974
+3% +$481K 0.04% 239
2015
Q4
$18.3M Sell
183,671
-7,661
-4% -$750K 0.04% 245
2015
Q3
$17.4M Buy
191,332
+11,013
+6% +$1.1M 0.04% 245
2015
Q2
$19.1M Buy
180,319
+6,577
+4% +$728K 0.04% 238
2015
Q1
$19.8M Buy
173,742
+4,697
+3% +$536K 0.04% 239
2014
Q4
$18.6M Sell
169,045
-6,178
-4% -$651K 0.04% 236
2014
Q3
$17.1M Buy
175,223
+60
+0% +$5.9K 0.04% 230
2014
Q2
$17.7M Sell
175,163
-1,554
-0.9% -$152K 0.04% 225
2014
Q1
$16.2M Sell
176,717
-7,287
-4% -$672K 0.04% 217
2013
Q4
$16.6M Sell
184,004
-2,977
-2% -$258K 0.04% 222
2013
Q3
$14.9M Buy
186,981
+3,708
+2% +$292K 0.04% 219
2013
Q2
$13.3M Buy
+183,273
New +$13.7M 0.03% 220

Other funds holding ZBH

Ken Fisher's ZBH Position: Q4 2025 in Review

Ken Fisher sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 4,395 shares — an estimated $433K sold.

Ken Fisher first reported a position in ZBH in Q2 2013 and held it in 50 quarters. The position peaked at $21.7M in Q2 2016. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Ken Fisher reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Ken Fisher sold 4,395 Zimmer Biomet shares in Q4 2025, an estimated $433K.
  • Ken Fisher first reported a position in Zimmer Biomet in Q2 2013 and held it in 50 quarters.
  • Ken Fisher's Zimmer Biomet position peaked at $21.7M in Q2 2016.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.